Potent stimuli combined with lipopolysaccaride and IFNγ may improve immunotherapy against HCC by increasing the maturation and subsequent immune response of the dendritic cells

Cancer Biotherapy and Radiopharmaceuticals

Volumn 18, Issue 1, 2003, Pages 1-6

  Iwashita, Yukio ^a   Goto, Shigeru ^a   Tahara, Kouichirou ^a   Kawano, Katsunori ^a   Chen, Chao Long ^b   Kitano, Seigo ^a  

^a OITA UNIVERSITY   (Japan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 LIGAND; CD86 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER IMMUNOTHERAPY; CELL MATURATION; CELL STIMULATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; MIXED LYMPHOCYTE REACTION; PRIORITY JOURNAL;

EID: 0037223659     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/108497803321269278     Document Type: Article

References (17)

1. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu Rev Immunol 1991; 9:271-296.
2. Kakumu S, Ito S, Ishikawa T, et al. Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol 2000; 15:431-436.
3. Ninomiya T, Akbar SM, Masumoto T, Horiike N, Onji M. Dendritic cells with immature phenotype and defective function in the peripheral blood from patients with hepatocellular carcinoma. J Hepatol 1999; 31:323-331.
4. Auffermann-Gretzinger S, Keeffe EB, Levy S. Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection. Blood 2001; 97:3171-3176.
5. Stevenson HC, Keenan AM, Woodhouse C, et al. Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis. Cancer Res 1987; 47:6100-6103.
6. Andreesen R, Scheibenbogen C, Brugger W, et al. Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy. Cancer Res 1990; 50:7450-7456.
7. Eymard JC, Lopez M, Cattan A, Bouche O, Adjizian JC, Bernard J. Phase I/II trial of autologous activated macrophages in advanced colorectal cancer. Eur J Cancer 1996; 32A:1905-1911.
8. Faradji A, Bohbot A, Schmitt-Goguel M, et al. Phase I trial of intravenous infusion of ex-vivo-activated autologous blood-derived macrophages in patients with nonsmall-cell lung cancer: toxicity and immunomodulatory effects. Cancer Immunol Immunother 1991; 33:319-326.
9. Hennemann B, Scheibenbogen C, Schumichen C, Andreesen R. Intrahepatic adoptive immunotherapy with autologous tumor cytotoxic macrophages in patients with cancer. J Immunother Emphasis Tumor Immunol 1995; 18:19-27.
10. Takeda T, Kobayashi T, Monden T, et al. The effect of local immunotherapy for breast cancer using a mixture of OK-432 and fibrinogen supplemented with activated macrophages. Biotherapy 1993; 7:47-54.
11. Schwamberger G, Flesch I, Ferber E. Characterization and partial purification of a high molecular weight tumoricidal activity secreted by murine bone marrow macrophages. Int Immunol 1992; 4:253-264.
12. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179:1109-1118.
13. Snijders A, Hilkens CM, van der Pouw Kraan TC, Engel M, Aarden LA, Kapsenberg ML. Regulation of bioactive IL-12 production in lipopolysaccharide-stimulated human monocytes is determined by the expression of the p35 subunit. J Immunol 1996; 156:1207-1212.
14. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature 1998; 392:245-252.
15. Huang YS, Hwang SJ, Chan CY, et al. Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Chung Hua I Hsueh Tsa Chih (Taipei) 1999; 62:327-333.
16. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 1997; 9:10-16.
17. Ulevitch RJ, Tobias PS. Recognition of gram-negative bacteria and endotoxin by the innate immune system. Curr Opin Immunol 1999; 11:19-22.